HLB Science (XKRX:343090) EV-to-EBIT : (As of May. 17, 2024)

View and export this data going back to 2020. Start your Free Trial

What is HLB Science EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, HLB Science's Enterprise Value is ₩44,823.14 Mil. HLB Science does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate HLB Science's EV-to-EBIT at this moment.

The historical rank and industry rank for HLB Science's EV-to-EBIT or its related term are showing as below:

XKRX:343090' s EV-to-EBIT Range Over the Past 10 Years
Min: -49.62 Med: 0 Max: 0
Current: -25.03

XKRX:343090's EV-to-EBIT is ranked worse than
100% of 431 companies
in the Biotechnology industry
Industry Median: 10 vs XKRX:343090: -25.03

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. HLB Science's Enterprise Value for the quarter that ended in . 20 was ₩0.00 Mil. HLB Science does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate HLB Science's Earnings Yield (Joel Greenblatt) % at this moment.

HLB Science EV-to-EBIT Historical Data

The historical data trend for HLB Science's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science EV-to-EBIT Chart

HLB Science Annual Data

Trend

Dec22

Dec23

EV-to-EBIT

-8.05

-21.55

HLB Science Quarterly Data

EV-to-EBIT

Competitive Comparison of HLB Science's EV-to-EBIT

For the Biotechnology subindustry, HLB Science's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HLB Science's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Science's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where HLB Science's EV-to-EBIT falls into.

HLB Science EV-to-EBIT Calculation

HLB Science's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	44823.142	/
	=

HLB Science (XKRX:343090) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

HLB Science's Earnings Yield (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: . 20 )	=	EBIT	/	Enterprise Value (Q: . 20 )
	=		/
	=	%

HLB Science EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of HLB Science's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Science (XKRX:343090) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR

Website

http://www.hlbscience.com

HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines